comparemela.com

Farzin Haque News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rigel Pharmaceuticals, Inc (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript

Rigel Pharmaceuticals, Inc (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesKristen kluskaDave santosYigal nochomovitzRaul rodriguezFarzin haqueRay fureyLisa rojkjaerMd anderson cancer centerCantor fitzgeraldRigel pharmaceuticals incRigel pharmaceuticalsCall transcript mayRigel pharmaceuticals financial conference callFirst quarterExecutive vice president

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript

Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.07464, expectations were $-0.17.

United statesFarzin haqueGreg keenanStacy kuAndrea christopherJoe millerPeter greenleafMaury raycroftInvestor relations for aurinia pharmaceuticalsExchange commissionAurinia pharmaceuticals first quarterHead of corporate communicationsAurinia pharmaceuticals incAurinia pharmaceuticalsCall transcript mayCorporate communications

Synaptics To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday - Illumina (NASDAQ:ILMN), Hawaiian Electric Indus (NYSE:HE)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

United statesChris dendrinosZach cumminsPiper sandlerJohn vinhJoshua reillyKyle miksonBrent bracelinSynaptics incorporatedJoseph feldmanBrett knoblauchCanaccord genuityJonathan reederFarzin haqueWynn resortsVera therapeutics inc

Jefferies upgrades this little-known biotech stock, with more than 100% upside

This biotech company could rally if its drug successfully treats autoimmune diseases affecting the kidneys.

Farzin haqueVera therapeuticsIga nephropathyLupus nephritisInvestment strategyStock marketsVera therapeutics incBiotech and pharmaceuticalsUnder the radarBusiness news

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Q3 2023 Earnings Call Transcript

Operator: Greetings. Welcome to Aurinia Pharmaceuticals Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

United kingdomUnited statesJamie harrellToni braxtonFarzin haqueJoe millerMaury raycroftPeter greenleafJoseph schwartzAurinia pharmaceuticals incWelcome to aurinia pharmaceuticals third quarterAmerican college of rheumatologyDisease awareness campaign get uncomfortableAurinia allianceInvestor relations for aurinia pharmaceuticalsOtsuka pharmaceuticals

vimarsana © 2020. All Rights Reserved.